ATMI LifeSciences and Austar Announce Completion of Beijing Biopharmaceutical Manufacturing Facility

ATMI, Inc. has further extended its global biopharma manufacturing footprint with the opening of a new Chinese manufacturing facility as part of a joint venture with Austar.

ATMI, Inc. has further extended its global biopharma manufacturing footprint with the opening of a new Chinese manufacturing facility as part of a joint venture with Austar, a Hong Kong-based comprehensive service provider to the China pharmaceutical industry. 

The joint venture, ATMI Austar LifeSciences Ltd, originated with the goal of producing and marketing high-end, ultra-clean sterile materials packaging for APIs and sterile pharmaceutical components to meet growing demand across the biopharmaceutical industry in the Asia-Pacific region. The new state-of-the-art manufacturing facility in Beijing, which was brought online today (26 October 2010) at an official Grand Opening ceremony attended by customers and Chinese FDA and government officials, represents a significant step toward that goal. 

Under the joint venture agreement, ATMI Austar LifeSciences will be producing certain ATMI LifeSciences products, including Cleansteam products, with local blow-film